The ROE as of September 2024 (TTM) for Viking Therapeutics, Inc. (VKTX) is -15.05%

According to Viking Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -15.05%. This represents a change of 224.91% compared to the average of -4.63% of the last 4 quarters.

Viking Therapeutics, Inc. (VKTX) Historical ROE (quarterly & annually)

How has VKTX ROE performed in the past?

The mean historical ROE of Viking Therapeutics, Inc. over the last ten years is -63.46%. The current -15.05% ROE has changed -76.29% with respect to the historical average. Over the past ten years (40 quarters), VKTX's ROE was at its highest in in the March 2015 quarter at 20.52%. The ROE was at its lowest in in the September 2017 quarter at -274.02%.

Viking Therapeutics, Inc. (VKTX) ROE by Quarter and Year

Discovering the peaks and valleys of Viking Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Viking Therapeutics, Inc. (VKTX) Average ROE

How has VKTX ROE performed in the past?

The current ROE of Viking Therapeutics, Inc. (VKTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Viking Therapeutics, Inc. (VKTX) ROE vs. Peers

How is VKTX’s ROE compared to its peers?

Viking Therapeutics, Inc.’s ROE is greater than Intercept Pharmaceuticals, Inc. (-78.24%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Akero Therapeutics, Inc. (-29.56%), less than Reata Pharmaceuticals, Inc. (19.32%), greater than Madrigal Pharmaceuticals, Inc. (-95.61%), less than Sarepta Therapeutics, Inc. (5.17%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), less than PTC Therapeutics, Inc. (57.03%), greater than Axsome Therapeutics, Inc. (-174.48%), greater than ImmunoGen, Inc. (-21.97%), less than Seres Therapeutics, Inc. (313.56%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), greater than Mereo BioPharma Group plc (-63.39%), less than AVROBIO, Inc. (29.68%), greater than CohBar, Inc. (-55.32%), less than Ocean Biomedical, Inc. (567.07%), greater than Enveric Biosciences, Inc. (-234.16%), greater than Elevation Oncology, Inc. (-57.97%),

Build a custom stock screener for Viking Therapeutics, Inc. (VKTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viking Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Viking Therapeutics, Inc. (VKTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Viking Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.